GMP – Page 39 – Pharma.Tips

Inadequate WHO GMP training during API sourcing – evidence pack for WHO audits

Addressing Insufficient WHO GMP Training in API Sourcing: A Comprehensive Playbook Inadequate WHO GMP training during API sourcing presents significant risks for pharmaceutical manufacturers, impacting compliance with international standards and…

Extended cleaning duration during validation lifecycle – cycle time reduction with compliance assurance

Reducing Cleaning Cycle Time During Validation Without Compromising Compliance In the ever-evolving landscape of pharmaceutical manufacturing, optimizing cleaning processes is a critical component of both operational efficiency and regulatory compliance.…

API site WHO GMP risk during API sourcing – CAPA aligned to WHO standards

Managing WHO GMP Risks During API Sourcing: An Actionable Playbook The procurement of Active Pharmaceutical Ingredients (APIs) from external suppliers poses significant risks related to WHO GMP compliance. Understanding these…

Documentation not aligned to WHO during API sourcing – avoiding repeat WHO observations

Ensuring Documentation Alignment with WHO Guidelines During API Sourcing Non-compliance with WHO GMP guidelines during Active Pharmaceutical Ingredient (API) sourcing can lead to significant regulatory observations and consequences. This article…

Inadequate WHO GMP training during prequalification preparation – CAPA aligned to WHO standards

Addressing Inadequate WHO GMP Training During Prequalification Preparation: A Comprehensive Playbook In the pharmaceutical industry, adherence to WHO GMP standards is critical in ensuring quality and compliance throughout the manufacturing…

WHO GMP gap identified during internal gap assessment – avoiding repeat WHO observations

Addressing Identified WHO GMP Gaps from Internal Assessments Pharmaceutical professionals know that maintaining compliance with WHO Good Manufacturing Practices (GMP) is not just about adhering to regulatory expectations; it also…

Equipment downtime due to cleaning during validation lifecycle – cycle time reduction with compliance assurance

Addressing Equipment Downtime from Cleaning in Validation Lifecycles for Enhanced Productivity In pharmaceutical manufacturing, equipment downtime due to cleaning during the validation lifecycle poses significant challenges to operational efficiency and…

Supplier WHO GMP non-compliance during internal gap assessment – CAPA aligned to WHO standards

Playbook for Addressing Supplier WHO GMP Non-Compliance During Internal Gap Assessments Supplier WHO GMP non-compliance can pose a significant risk to pharmaceutical manufacturers, especially during internal gap assessments. Addressing these…

Inadequate WHO GMP training during internal gap assessment – CAPA aligned to WHO standards

Addressing Insufficient WHO GMP Training in Internal Gap Assessments In the complex landscape of pharmaceutical manufacturing, ensuring compliance with WHO GMP standards is critical. Inadequate training during internal gap assessments…

API site WHO GMP risk during WHO inspection – avoiding repeat WHO observations

Mitigating API Site Risks During WHO Inspections: A Practical Playbook Pharmaceutical manufacturers face a growing imperative to maintain compliance with WHO Good Manufacturing Practice (GMP) standards. The increasing scrutiny during…

Inefficient CIP cycle during validation lifecycle – inspection-ready cleaning optimization

Addressing Challenges in CIP Cycle Inefficiencies During the Validation Lifecycle As pharmaceutical manufacturing processes continuously evolve, the demand for effective and efficient cleaning processes is emphasized, especially during the validation…

Repeated GMP deviations during internal audit – evidence package for inspection defense

Addressing Persistent GMP Deviations During Internal Audits: A Playbook for Compliance In the complex world of pharmaceutical manufacturing, repeated GMP deviations during internal audits can threaten product quality, regulatory standing,…